// company-profile

InMed Pharmaceuticals Inc.

INM
ExchangeNasdaqSectorPharmaceutical PreparationsInc.A1Filings51Insiders19
// api This InMed Pharmaceuticals Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 14 insiders purchased shares (net $246K). Buying was led by Vivo Opportunity, LLC.

// 90-day insight

Over the last 90 days, InMed Pharmaceuticals Inc. insiders bought $1.1M across 21 transactions with no open-market sales.

  • Most active insider: Vivo Opportunity, LLC with 18 transactions totaling $392K.
  • Largest single purchase: $312K by ADAR1 Capital Management, LLC on May 19, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of InMed Pharmaceuticals Inc. as of 2026-03-31

— stable
Total reported AUM
$193,047
QoQ change
Reporting period
2026-03-31
#1
SABBY MANAGEMENT, LLC
CIK 1535610
$142,046
220K shares
#2
CITADEL ADVISORS LLC
CIK 1423053
$30,293
47K shares
#3
TWO SIGMA SECURITIES, LLC
CIK 1450144
$12,071
19K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 8, 2026Vivo Opportunity, LLCINM
Purchase
29,518$1.52$45K
Jun 8, 2026Vivo Opportunity, LLCINM
Purchase
2,982$1.52$5K
Jun 5, 2026Vivo Opportunity, LLCINM
Purchase
5,045$1.57$8K
Jun 5, 2026Vivo Opportunity, LLCINM
Purchase
49,966$1.57$78K
Jun 4, 2026Vivo Opportunity, LLCINM
Purchase
618$1.57$1K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.